Bayer SG&A Expenses 2010-2024 | BAYRY

Bayer sg&a expenses for the twelve months ending December 31, 2024 were $17.247B, a 6.7% increase year-over-year.

  • Bayer annual sg&a expenses for 2024 were $17.247B, a 6.7% increase from 2023.
  • Bayer annual sg&a expenses for 2023 were $16.164B, a 9.34% decline from 2022.
  • Bayer annual sg&a expenses for 2022 were $17.829B, a 1.67% decline from 2021.

Bayer SG&A Expenses 2010-2024 | BAYRY

  • Bayer annual sg&a expenses for 2024 were $17.247B, a 6.7% increase from 2023.
  • Bayer annual sg&a expenses for 2023 were $16.164B, a 9.34% decline from 2022.
  • Bayer annual sg&a expenses for 2022 were $17.829B, a 1.67% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Innoviva (INVA)$1.1B